Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
There is limited high-quality clinical research evaluating its safety, especially for long-term or repeated use
Compounded versions are created by accredited pharmacies and contain the same active ingredient but allow for flexible dosing and pricing
Fastest results come from pairing the medication with consistent protein intake (0.71g per lb of target weight), strength training 23x/week, and 78 hours of sleep
Retatrutide is the successor to Novo Nordisk's GLP-1 drugs Ozempic/Wegovy (Semaglutide) and Eli Lilly's Mounjaro/Zepbound (Tirzepatide)
Whether this unique pattern worsens the obese state or constitutes a favorable adaptation remains unclear, and the physiological and pathophysiological implications of the altered GH/IGF-I axis in obesity remain uncertain with GH neither being the cause nor the solution to reverse obesity
